Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arcturus Therapeutics Ltd (ARCT)

Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 433,934
  • Shares Outstanding, K 27,087
  • Annual Sales, $ 166,800 K
  • Annual Income, $ -29,730 K
  • EBIT $ -81 M
  • EBITDA $ -78 M
  • 60-Month Beta 2.64
  • Price/Sales 2.92
  • Price/Cash Flow N/A
  • Price/Book 1.89

Options Overview Details

View History
  • Implied Volatility 71.74% ( +4.92%)
  • Historical Volatility 62.59%
  • IV Percentile 32%
  • IV Rank 40.41%
  • IV High 125.01% on 11/04/24
  • IV Low 35.61% on 08/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 85
  • Volume Avg (30-Day) 209
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 5,748
  • Open Int (30-Day) 5,924

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.45
  • Number of Estimates 4
  • High Estimate 0.59
  • Low Estimate -1.11
  • Prior Year -0.32
  • Growth Rate Est. (year over year) -40.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.93 +12.39%
on 11/15/24
21.61 -22.35%
on 11/11/24
-4.37 (-20.66%)
since 10/18/24
3-Month
14.93 +12.39%
on 11/15/24
25.88 -35.16%
on 10/02/24
-3.42 (-16.93%)
since 08/16/24
52-Week
14.93 +12.39%
on 11/15/24
45.00 -62.71%
on 06/05/24
-8.21 (-32.85%)
since 11/17/23

Most Recent Stories

More News
Arcturus Therapeutics: Q3 Earnings Snapshot

Arcturus Therapeutics: Q3 Earnings Snapshot

ARCT : 16.74 (+4.49%)
New Strong Buy Stocks for September 13th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Arcturus Therapeutics Holdings Inc. ARCT: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings...

ANGO : 6.84 (+0.44%)
PAM : 80.48 (+5.37%)
ARCT : 16.74 (+4.49%)
MHO : 155.73 (+0.17%)
FMBH : 42.02 (+0.07%)
Arcturus Therapeutics: Q2 Earnings Snapshot

Arcturus Therapeutics: Q2 Earnings Snapshot

ARCT : 16.74 (+4.49%)
Stocks See Support from Chip Stocks But T-Note Yield Rises

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.32%. US stock indexes...

$SPX : 5,897.23 (+0.45%)
SPY : 588.61 (+0.49%)
$DOWI : 43,451.82 (+0.02%)
DIA : 434.68 (+0.04%)
$IUXX : 20,590.28 (+0.96%)
QQQ : 501.57 (+1.01%)
ZNZ24 : 109-130 (-0.11%)
MRNA : 38.51 (+4.50%)
ZS : 204.23 (+1.37%)
PNR : 105.98 (+0.06%)
LULU : 313.90 (-1.91%)
PEP : 159.67 (+0.66%)
Stocks Mixed in TodayAfternoon Trade

The S&P 500 Index ($SPX ) (SPY ) today is down -0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.39%. US stock indexes today are...

$SPX : 5,897.23 (+0.45%)
SPY : 588.61 (+0.49%)
$DOWI : 43,451.82 (+0.02%)
DIA : 434.68 (+0.04%)
$IUXX : 20,590.28 (+0.96%)
QQQ : 501.57 (+1.01%)
ZNZ24 : 109-130 (-0.11%)
NVDA : 140.59 (-0.98%)
MU : 97.51 (+1.21%)
ASML : 664.31 (+0.86%)
AMD : 140.08 (+3.84%)
QCOM : 164.71 (+2.62%)
Stocks See Mild Pressure from Hawkish Fed Comments

The S&P 500 Index ($SPX ) (SPY ) today is down -0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.07%. US stock indexes today are...

$SPX : 5,897.23 (+0.45%)
SPY : 588.61 (+0.49%)
$DOWI : 43,451.82 (+0.02%)
DIA : 434.68 (+0.04%)
$IUXX : 20,590.28 (+0.96%)
QQQ : 501.57 (+1.01%)
ZNZ24 : 109-130 (-0.11%)
AAPL : 228.69 (+1.64%)
NVDA : 140.59 (-0.98%)
MU : 97.51 (+1.21%)
ASML : 664.31 (+0.86%)
AMD : 140.08 (+3.84%)
Why Shares of Arcturus Therapeutics Dropped on Tuesday

The company saw revenue decline and net losses rise in the second quarter.

ARCT : 16.74 (+4.49%)
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines...

ARCT : 16.74 (+4.49%)
Why Arcturus Therapeutics Stock Is Soaring Today

Investors liked what they heard in its Q4 update.

ARCT : 16.74 (+4.49%)
Markets Today: Stock Indexes Climb as Tech Strength Buoys Sentiment

Morning Markets March S&P 500 futures (ESM2 3) this morning are up +0.79%, and March Nasdaq 100 E-Mini futures (NQM2 3) are up +0.82%. U.S. stock index futures this morning are moderately higher. Technology...

ESZ24 : 5,921.50 (+0.42%)
NQZ24 : 20,692.25 (+0.97%)
LULU : 313.90 (-1.91%)
MU : 97.51 (+1.21%)
AMD : 140.08 (+3.84%)
INTC : 24.27 (-0.33%)
NVDA : 140.59 (-0.98%)
QCOM : 164.71 (+2.62%)
ARCT : 16.74 (+4.49%)
HIG : 117.29 (-0.56%)
CCL : 24.53 (+0.90%)
NABL : 10.39 (-1.42%)

Business Summary

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as...

See More

Key Turning Points

3rd Resistance Point 20.77
2nd Resistance Point 19.39
1st Resistance Point 17.70
Last Price 16.74
1st Support Level 14.63
2nd Support Level 13.25
3rd Support Level 11.56

See More

52-Week High 45.00
Fibonacci 61.8% 33.51
Fibonacci 50% 29.97
Fibonacci 38.2% 26.42
Last Price 16.74
52-Week Low 14.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar